Requests similar to 'Equity of access for low side-effect formulations for therapeutic treatment of anxiety, depression & ADHD' (page 5)

Kia ora Nigel Please see attached the University of Otago's response to your Official Information Act request dated 8 December 2022. Ngā mihi Kelsey...
Monoclonal antibodies
Response by Ministry of Health to M.R.M. on .
Long overdue.
Kia ora M.R.M Please find attached a letter regarding your request for information. Ngā mihi OIA Services Government Services Office of the Dir...
Best practice nutritional advice chronic conditions
Request sent to Ministry of Health by J Bruning on .
Successful.
Deficiency in key nutrients, the effect of ultraprocessed and high-carbohydrate diets and insulin resistance in driving many chronic conditions whic...
ADHD and Maori/Pacific
Response by Pharmaceutical Management Agency to Rodney Parsons on .
Successful.
Kia ora Rodney,   Please find attached a response to your Official Information Act request, which was received on 22 October 2024.   Please co...
Kia ora Jimmy Please find attached a response to your request for official information. Ngā mihi     OIA Services Team Manatū Hauora | Ministr...
CV-ISMB Memos & Associated Information
Response by Ministry of Health to Chris McCashin on .
Partially successful.
Kia ora Chris    Partial response to your request for official information    Thank you for your request under the Official Information Act 198...
The provisional approval in the Gazette for the Comirnaty medicine had 8 conditions here https://www.medsafe.govt.nz/COVID-19/Comirnaty-Gazette-Oct-2...
COVID-19 Health System Preparedness Programme
Response by Ministry of Health to Harold on .
Successful.
Kia ora Harold, The second part of the response documents is attached to this email. Ngā mihi     OIA Services Team  M[1]inistry of Health inf...
EACD Reports on BZP in NZ
Response by Ministry of Health to K Piper on .
Awaiting classification.
Kia ora K Piper   Please find attached the response to your request for official information.   Nga mihi,   Caitlin Finnegan-Ramanui Advi...
Annotation: Transparency in COVID-19 Vaccine Warnings and Adverse Event Reporting – Insights from OIA Request #32014 For New Zealanders Following Vac...
Funding for Ixekizumab
Response by Pharmaceutical Management Agency to Ms Faulkner on .
Successful.
Kia ora Ms Faulkner, Please find a response to your request attached to this email. Kind regards, Gendi McFadyen| Government Services Advisor Te Pāt...
Kia ora Erika,   Please find attached a response to your official information act request   Ngā mihi    OIA Services Government Services...
Dear Amanda   Thank you for your query regarding the availability and funding for estradiol, testosterone and anti-androgen pharmaceuticals in New...
CV-ISMB Summary of Safety Signals
Response by Ministry of Health to Chuck Schooner (Account suspended) on .
Awaiting classification.
Kia ora Chuck Please find attached a response to your request for official information. We apologise for the delay in providing you with this respons...
AOH1996 pill
Response by Medicines Classification Committee to Chris on .
Successful.
 Kia ora Chris   Please find a response to your request attached to this email.     Ngâ mihi,   Katy Carlson ([1]she/her) | Government Se...
Missed time from work considered?
Response by Pharmaceutical Management Agency to PCBS on .
Successful.
Kia ora Paul   Please find attached a response to your request for official information.   Ngā mihi,   Government Services | Pharmac 2 Jul...
Disinformation Document Questions
Response by Department of the Prime Minister and Cabinet to Jai Ganesh on .
Information not held.
Kia ora Jai,   Thank you for your request under the Official Information Act 1982 (the Act) to Manatū Hauora (the Ministry of Health) on 30 Novemb...
Informed Consent
Response by Ministry of Health to Annie Weston on .
Long overdue.
Kia ora Annie, Thank you for your email. I will respond to each part of your request in turn: A copy of Pfizer’s contract with the NZ Govt.  I do no...
Kia ora Anna,   Thank you for your request for information regarding Omeprazole / PPI prescribing in children and young people on 22 March 2023.  Pl...
Differences between BNT162b2 and Comirnaty®
Response by Ministry of Health to ASE on .
Awaiting classification.
Kia ora ASE   Please see attached a response to your request for official information.     Ngā mihi       OIA Services Team Manatū Ha...
Medicinal cannabis products recalls
Response by Ministry of Health to M WOODWARD on .
Awaiting classification.
Kia ora M Woodward,   Please find attached our response to your official information request.   Ngā mihi       OIA Services Team Manatū...
    Kind regards,   Heather Mathie (she/her) Planning and Reporting Advisor | Strategy, Regulatory and Support Archives New Zealand Te Rua M...
Kia ora B Haddock   Please find attached the response to your request for official information.   Nga mihi,   Caitlin Finnegan-Ramanui Ad...
Kia ora Catherine,    Thank you for your request for information regarding Variation of Expiry dates of Paediatric Covid 19 vaccines. Please find at...
I have amended my request as follows which is specifically directed to MoH Strategy policy & legislation Deputy Director General Maree Roberts and h...